THIS IS AN ADVERTISING FEATUREAfter almost 40 years with Aberdeen Asset Management (now abrdn) ? including 28 years founding and running abrdn Asia Focus investment trust (AAS) ? venerable Asia hand Hugh Young is finally to hang up his managerial boots, or at least leave them on the step for his teammate and successor Gabriel Sacks to step into.They?re undoubtedly big boots to fill. Morningstar da

Experience counts in the asset management industry and in a phenomenal achievement, Peter Spiller (pictured) recently celebrated his 40th anniversary at the helm of wealth preservation specialist Capital Gearing Trust (CGT).The mind boggles when you consider that during his four decades as manager, Spiller has seen seven UK prime ministers elected, countless international conflicts rage and inflat

Risk-on appetite returned to markets following the US presidential election result and encouraging news on a Covid-19 vaccine, which augurs well for equities across Asia, the vast geographic region which remains well positioned as the powerhouse of global growth.Flush with regional bargains is investment trust Aberdeen Standard Asia Focus (AAS), trading on a 15.2% discount to net asset value which

While a bitter battle with former chief executive Andrew Tinkler seethes in the background, infrastructure services firm Stobart (STOB) is busily making a key strategic decision.As part of a capital review the owner of Southend Airport is to cut its full year dividend from 16.5p to 15p, aas a result of the fourth quarter dividend being cut from the previously quarterly total of 4.5p to 1.5p.Broker

Shares in biotechnology firm AquaBounty Technologies (ABTU:AIM) last week (20 May) experienced a 200%+ surge to 42.95p as Health Canada approved its genetically modified AquAdvantage salmon (AAS) for sale in restaurants and fishmongers in Canada. The shares have since eased back, but still remain considerably ahead year-to-date at 35p.Investors are excited about the approval of the fast-growing fi

Biotechnology firm AquaBounty Technologies (ABTU:AIM) swims to a five-year high as Health Canada approves its AquAdvantage salmon (AAS) for commercial sale in Canada.Investors are excited about the approval of the wild and sustainable salmon stock, which requires 20-25% less feed than other farmed Atlantic salmon.Shares are up 200% to 40.5p.AquaBounty is a small company based in Massachusetts, US,

The top 10 best-performing investment trusts have delivered an average 12.1% compound annual return* over the past 25 years, illustrating the power of investing in the stock market. This is according to new data from the Association of Investment Trusts (AIC).This article looks at the leaders over this period, and the best performers on a 10-year basis. This list of winners can give you a good sta

Summer 2013's taper tantrum now feels like a distant memory as the Asia-Pacific region's stock markets trade at their highest levels since June 2008, according to the MSCI index benchmark. Worries over Chinese economic growth linger, while the twelfth military coup in Thailand since 1932 brings additional uncertainty to the region and investor reaction to any eventual increase in US interest rates

The FTSE 100 struggled to get the new week off to a good start, dipping 0.6% to 6,082. The results calendar looks bare for the large cap stocks this week, meaning that the index is likely to be purely driven by investor sentiment towards macro events.A widely-expected poor takeover offer has emerged for Eurasian Natural Resources (ENRC), leaving the stock flat at 217.4p. The real loser in the deal

It is tempting to jump aboard the rally presently in train at Jupiter Fund Management (JUP). As equity markets have surged to levels last seen before the collapse of Lehman Brothers in 2008 the firm has performed particularly well. That said, this should be no surprise since 80% of its assets under management (AUM) are in equities and 75% of AUM are held by the retail investor.The unfortunate real

The Retail Distribution Review, due to be implemented at the end of 2012, gives us all every incentive to take greater control of our financial destiny. Given the breadth and scope of the different options on offer it would be easy to feel intimidated but there are tools out there which are tailor-made for you, the investor, and which will help you construct a well-balanced portfolio designed to b